Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/Press Conference to Unveil New and Innovative Ads for Post-Exposure Prevention Project and Review Findings From the First Year of PEP.


--(BW HealthWire)--
FROM: Joint announcement from San Francisco Department of Public
      Health and UCSF AIDS Research Institute

RE:   Press Conference to unveil new and innovative ads for
      Post-Exposure Prevention Project (PEP) and review findings from
      the first year of PEP.

WHEN: Tuesday, Oct. 13
      10 a.m.

WHERE: San Francisco General Hospital Medical Center -- Main Lobby
       1001 Potrero Avenue, San Francisco

FOCUS:

     An innovative advertising campaign designed to inform gay men
about a successful program in HIV prevention is being launched in San
Francisco. Operated jointly by the San Francisco Department of Public
Health and the UCSF AIDS Research Institute, the program is the

Post-Exposure Prevention (PEP) Project. PEP is an effort to prevent
HIV infection by offering free, comprehensive treatment to people
exposed to HIV. During its first year, PEP enrolled more than 200
participants.
     PEP is marking its first-year anniversary with the new campaign,
which features two provocative ads. One ad will appear on the interior
and exterior of MUNI buses, on billboards, on bus shelters, and in
newspaper ads. The second ad will be placed in bars, dance clubs, and
sex clubs that cater to gay men and gay men of color. Both ads will
appear in English and Spanish.

SPEAKERS:

     --   Mitchell H. Katz, MD, Director, SF Department of Public
          Health
     --   Thomas Coates, PhD, Director, UCSF AIDS Research Institute,
          and Principal Investigator of the PEP Project
     --   James O. Kahn, MD, Medical Director of the PEP Project and
          UCSF Associate Professor of Medicine

PHOTO OP:

     -- MUNI bus with ad scheduled.
     -- Samples of ads on display.
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 12, 1998
Words:257
Previous Article:New Royalty Reigns in Pasadena; Seven Members of the 1999 Pasadena Tournament of Roses Royal Court Chosen From More Than 800 Pasadena-Area Young...
Next Article:Spy Glasses, Raptor Heads and Space Alien IDs Notable Contemporary Film Props on the Auction Block.



Related Articles
Rx: antidote for HIV?
Human Rabies Postexposure Prophylaxis during a Rac Rabies Epizootic in New York, 1993 and 1994.
Risk for Rabies Transmission from Encounters with Bats, Colorado, 1977-1996.
Nevirapine Warning on Post-Exposure Prophylaxis.
HIV Postexposure Prophylaxis in the 21st Century.
Meds for the morning after.
Evaluation of state-provided Postexposure Prophylaxis against Rabies in Florida.
Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. (Bioterrorism-Related Anthrax).
Research on postexposure prophylaxis for HIV.
Rabies postexposure prophylaxis, New York, 1995-2000.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles